B.Braun Medical

B. Braun Medical Inc. plans to spend $150 million to expand its assembly plant in Daytona Beach, Florida, adding 100 jobs. The company has acquired 35 acres adjacent to the plant and expects to start selling IV solution products by Q2 2020.

B. Braun Medical Inc. announced Solutions for Life, a $1 billion investment including a new manufacturing facility in Daytona Beach, FL, and modernizations to existing facilities in Irvine, CA, and Allentown, PA, to expand IV fluid production capacity.

B. Braun Medical Inc. has signed an agreement to acquire the bloodlines business operated under the Medisystems name by NxStage Medical Inc. The acquisition is subject to FTC approval and contingent upon NxStage's merger with Fresenius Medical Holdings, expected to close in 2018.

B. Braun Medical Magyarország will build a HUF 30.7 billion intravenous kit plant at its base in Gyöngyös, Hungary. The government is providing a HUF 6.1 billion grant.

B. Braun Médical has confirmed a €60 million investment over five years to expand production capacity and add 3,000 sq m of clean rooms at its Nogent-le-Rotrou site in France. Construction starts in 2019, with new machines installed in 2023.

B.Braun Melsungen AG plans to expand production at its Gematik plant in Tver, Russia, with investments of over 3 billion rubles over five years. The project includes construction of a production and logistics complex for medical devices, sutures, orthopedic implants, and disinfectants, creating 250 jobs.